Crestline Management, LP Agios Pharmaceuticals, Inc. Transaction History

Crestline Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$59.83 - $86.53 $1.42 Million - $2.05 Million	-23,727 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$52.12 - $72.33 $276,131 - $383,204	-5,298 Reduced 18.25%	23,727 $1.36 Million
Q3 2017 Nov 14, 2017	BUY	$54.89 - $67.12 $1.59 Million - $1.95 Million	29,025	29,025 $1.94 Million

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.87B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.